200K for Screening & Detection Research

BCC, in collaboration with AstraZeneca, is proud to announce the recipients of new funding dedicated to research in breast cancer screening and detection. The partnership includes additional in-kind support from Illumina Canada and sought to identify two Canadian research teams committed to advancing breast cancer screening or detection through the integration of precision diagnostics and […]